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Abstract 13 
Quorum sensing molecules (QSMs) regulate, through a chemical communication process, 14 
multiple complex systems in bacterial and some fungal populations on the basis of cell-15 
density. The bacterial QSMs involved in inter-kingdom cross-talk may exhibit antagonistic 16 
activity against fungi. This provides an important opportunity for bio-control of fungal 17 
invasion in plants. It has been shown that cultures of Bacillus spp. inhibit fungal growth. 18 
Here, we explore the inhibitory potential of the industrial workhorse Bacillus licheniformis 19 
NCIMB-8874 and its QSM (ComX pheromone) on the growth of Aspergillus flavus, a cereal, 20 
legume and nut crop pathogen. Our studies show that ComX filtered extracts from cultures 21 
of B. licheniformis can cause a significant reduction in the growth of A. flavus NRRL 3357 and 22 
ESP 15 at a concentration as low as 13 µgml-1. This work evidences, for the first time, the 23 
inter-kingdom utility of the bacterial quorum sensing ComX pheromone indicating potential 24 
antifungal food security against A. flavus. 25 
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Quorum Sensing (QS) is an intra- and interspecies microbial communication process based 2 
on cell-density found in bacteria and fungi (Nealson et al. 1970; Fuque et al. 1994; Hogan 3 
2006). In many bacterial species, more than one class of compound engage in the network 4 
of regulatory systems controlling the response of a bacterial population to environmental 5 
changes, by regulating diverse genes (Atkinson and Williams 2009). QS mechanisms in 6 
bacteria are often classified into three different cell communication systems operating in i) 7 
Gram-negative bacteria, ii) Gram-positive bacteria, and iii) both groups of bacteria as a 8 
universal QS system (Miller and Bassler 2001). In filamentous fungi, when QSMs of e.g. 9 
Aspergillus terreus, A. flavus or A. nidulans are exogenously added to their own fungal 10 
cultures, they effect morphological changes as well as secondary metabolite production 11 
such as lovastatin, penicillin and aflatoxin (Schimmel et al. 1998; Brown et al. 2008 and 12 
2009; Williams et al. 2012). 13 
Inter-kingdom chemical signalling involved in parasitic and symbiotic relationships with 14 
unicellular and complex eukaryotes is mediated through the cross-sensing of pheromone 15 
and pheromone-like compounds, including QSMs (Fox 2004; Rumbaugh 2007; Mullard 16 
2009). These communication networks are also subject to significant plasticity on account of 17 
enzymatic modification and degradation of the signalling molecules involved. For instance, 18 
one of the bacterial QSMs, Acyl-Homoserine Lactone (AHL), which directs bacterial 19 
compound synthesis, is also recognised by animal, plant, seaweed and fungal cells (Dudler 20 
and Eberl 2006). Animal cell gene expression in response to QSMs has been reported to be 21 
altered in an immune modulatory fashion (Sperandio 2003; Shiner et al. 2005). In green 22 
seaweed, Joint et al. (2002) demonstrated that Enteromorpha zoospores are attracted by 23 
synthetic AHLs to settle on bacterial biofilm microcolonies in an AHL concentration-24 
dependent manner. In higher plants, the Medicago truncatula legume (Mathesius et al. 25 
2003) and the tomato rhizosphere (Schuhegger et al. 2006) have also been reported to 26 
respond to bacterial AHL signalling. In the legumes, the concentration of more than 150 27 
proteins is altered, whereas AHL in tomato rhizospheres increases salicylic acid 28 
concentration in the plants’ leaves, thereby enhancing systemic resistance against the 29 
fungal leaf pathogen Alternaria alternate. The latter evidence suggests that AHLs play an 30 
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important role in the bio-control activity of rhizobacteria (Mathesius et al. 2003; Schuhegger 1 
et al. 2006). 2 
On the other hand, several reports indicate that fungi interfere with bacterial QS by 3 
producing AHL antagonists (Rasmussen et al. 2005). Plant defence signals such as salicylic 4 
acid have been reported to up-regulate the expression of an AHL-degrading enzyme in 5 
Agrobacterium tumefaciens. Alternatively, AHL-antagonists are produced by plants and 6 
fungi to block bacterial QS (Bauer and Mathesius 2004; Dudler and Eberl 2006; Williams 7 
2007). Elsewhere, it has been reported that the Candida albicans QSM compound, farnesol, 8 
suppresses transcription of the Pseudomonas aeruginosa quinolone signal (PQS) QSM 9 
(Cugini et al. 2007). Interestingly, Lee and colleagues (Lee et al. 2015) recently reported that 10 
farnesol can also block eukaryotic signalling pathways (e.g. STAT3) in mice, potentially 11 
exerting, anti-proliferation and pro-apoptotic activities on tumours. 12 
Inter-kingdom communication also underpins food security through regulation of the 13 
metabolism of fungi with pathogenic and saprophytic potential in agricultural crops. 14 
Aspergillus species are common soil saprophytes found worldwide, responsible for pre-15 
harvest and post-harvest disease in several agricultural seed crops (Amaike and Keller 2011). 16 
Among these fungi, A. flavus and A. parasiticus are the predominant species responsible for 17 
aflatoxin contamination of crops prior to harvest or during storage (Miller 1995; Yu et al. 18 
2004; Gokmen et al. 2005). At the same time, A. fumigatus and A. flavus are the primary 19 
causes of mould aspergillosis in man. Thus, respiratory (Dufresne et al. 2017), cutaneous 20 
(Raiesi et al. 2017), ocular (Zhao et al. 2016) and even systemic infections (Gabrielli et al. 21 
2014) may arise, not only in agricultural settings (Porpon et al. 2017; Viegas et al. 2016), but 22 
also in immunocompromised individuals (Wiesmüller et al. 2017; Porpon et al. 2017), and 23 
with increasing resistance (Meis et al. 2016) to mainstay antifungal–azole therapy (Park et 24 
al. 2017). 25 
Importantly, aflatoxins are considered as the most significant mycotoxins due to their 26 
occurrence, toxicology and impact on human well-being and crop trade (Gnonlonfin et al. 27 
2013). Aflatoxin is mainly a problem in maize because this crop is colonized in the field 28 
depending on environmental conditions. Of the other grains, rice is an important dietary 29 
source of aflatoxin associated to poor grain-storage in tropical and subtropical areas (Miller 30 
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1995). Similarly, fungal aflatoxins have been recently demonstrated to inhibit mucocilliary 1 
beating in mammalian airways (Lee et al. 2016), thereby contributing to respiratory mucous 2 
accumulation and exacerbation of in patients with chronic obstructive pulmonary disease 3 
(COPD) or cystic fibrosis (CF). Together, the food security and medical risk potential 4 
presented by Aspergillus spp. and aflatoxins define an unmet need for effective protection 5 
and prevention both in crops and man. Yet, to date, traditional pre-harvest control 6 
methods, irrigation and identification of plant defence proteins do not appear to be able to 7 
control Aspergillus crop contamination (Campbell and White 1995; Payne 1998; Chen et al. 8 
2010), whereas, the malleability of Aspergillus QS and its utility in the agrochemical and 9 
respiratory medicine context remains unexplored. 10 
We have recently identified and described the B. licheniformis NCIMB 8874 QS pheromone 11 
ComX (Esmaeilishirazifard et al. 2017). In this study, the pheromone potential of the 12 
putative B. licheniformis NCIMB 8874 QS genes (comQX) was identified through whole 13 
genome sequencing and explored through recombinant over-expression in Escherichia coli 14 
(Esmaeilishirazifard et al. 2017). Here, we report for the first time an antifungal property for 15 
the B. licheniformis ComX pheromone peptide, through antagonism to A. flavus. Its impact 16 
on fungal growth is analysed using a novel image analysis algorithm (ColonyAreaAnalyzer) 17 
developed for this project (Esmaeilishirazifard 2016, supporting information Figs. S1-S3). 18 
Furthermore, the impact of this QS peptide and other treatments on fungal growth as well 19 
as the biotechnological control of aflatoxin contamination are discussed.  20 
Materials and methods 21 
Strains, media and general methods 22 
B. licheniformis NCIMB 8874, available in the Culture Collection of the University of 23 
Westminster, London, UK, was used for investigation of the effect of QSM and bacterial cells 24 
on fungal growth. Lysogeny broth (LB) and LB agar (LBA) (Sigma) were used for the 25 
maintenance of B. licheniformis NCIMB 8874.  26 
Pheromone producer strain (the plasmid was constructed and transferred into E. coli BL21 27 
(DE3) by standard techniques) (Esmaeilishirazifard et al. 2017) was cultivated in M9 minimal 28 
salts solution (sigma). The medium was supplemented with a mixture of filter-sterilised 29 
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amino acids (leucine, phenylalanine, histidine, serine, 40 µgml-1 each; glutamine,  1 
400 µgml-1), and ampicillin (100 µgml-1). According to the manufacturer instruction, 2 
additional supplementation of filter-sterilised 20% (w/v) glucose, 1 M magnesium sulfate 3 
and 1 M calcium chloride was required in order to complete M9 minimal medium 4 
preparation. Filter sterilisation was carried out through a 0.22 µm filter (Millipore). 5 
A. flavus, NRRL 3357 (aflatoxigenic strain) and ESP 15 (non-aflatoxigenic strain) were kindly 6 
obtained from Prof. Naresh Magan, Department of Environmental Science and Technology, 7 
Cranfield University. Potato dextrose agar (PDA) was used for propagation and sporulation 8 
of A. flavus strains. For spore inoculation of the PDA plates, spores were extracted from the 9 
fully sporulated slants/plates using sterile 0.01% Tween 80 (v/v) supplemented with 2 mm 10 
glass beads (VWR). Spores were counted using a haemocytometer and adjusted to the 11 
desired inoculums concentration before inoculating the PDA plates. 12 
Pheromone over-production, purification and fungal-growth test 13 
E. coli BL21 ComX producer strain (Please refer to the method of preparation of this 14 
recombinant strain described in our previous work, Esmaeilishirazifard et al. 2017) was 15 
grown overnight in the completed M9 minimal salts medium described earlier. At stationary 16 
phase, this pre-culture (20 ml) was added to 1980 ml of the supplemented M9 medium to 17 
make 2 L bacterial culture (5 flasks in total to prepare 10 liters culture) and then incubated 18 
at 37 °C and 110 rpm for 8 h. QS gene (comQX) expression was induced with 0.5 mM 19 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) at 37 °C and 110 rpm overnight. Before and 20 
after the addition of IPTG, 10 ml samples were collected as treatments for the fungal growth 21 
test. The culture broth (10 L) was centrifuged for 10 min at 8,000 g. The supernatant was 22 
filtered through a 0.22 µm vacuum filtration unit Corning (Sigma). Reverse-phase 23 
chromatography method was performed for the initial purification and concentration of the 24 
filtered supernatant using Diaion HP-20 resin. The dried extract from reverse-phase 25 
chromatography was re-dissolved in 1% DMSO to prepare a solution of 5 and 30 mgml-1. To 26 
prepared washed cells of B. licheniformis NCIMB 8874, the cells were washed three times 27 
with sterile water by spinning at 7000 rpm for 10 min. All the treatments and associated 28 
controls are listed and labelled in Table S4. The images of the plates were taken every 24 h 29 
during the 7-day study. All results are presented as a mean ± standard error of two 30 
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independent experiments performed in triplicates. The diagram in Fig. 1 shows the stages 1 
that were followed to perform this experiment. 2 
Fungal dry weight measurement 3 
Fungal strains (A. flavus NRRL 3357 and ESP 15) grown in the shaken tubes contained  4 
10 ml PDB with all the applied treatments as described for the fungal growth experiment 5 
(Table S4). Each tube was inoculated with the prepared spore suspension with the final 6 
concentration of 10 spore.ml-1.  The cultures were incubated for 7 days in the incubator 7 
shaker at 180 rpm, 27 °C. Then they were harvested and filtered using grade No. 54 filter 8 
paper (22 µm pore size) (Whatman). These filter papers were kept at 70 °C for 24 h, cooled 9 
down to room temperature in desiccators and pre-weighted. Filter papers containing fungal 10 
mass were dried at 70 °C in the oven for 48 h, cooled down to room temperature in a 11 
desiccator before weighing. The difference between the weight of the filter paper and the 12 
combined weight of the filter paper together with fungal dried mycelia was considered as 13 
fungal dry weight. 14 
Antifungal susceptibility assays for pheromone 15 
The activities of the purified pheromone determined against A. flavus (aflatoxigenic strain) 16 
using micro-broth dilution assay (du Toit and Rautenbach 2000). According to the M38-A 17 
standard protocol for moulds, the medium RPMI-1640 (Sigma) containing L-glutamine and 18 
phenol red (as a pH indicator) (Sigma) was used for growth of A. flavus in antifungal 19 
susceptibility study. The medium was supplemented with filter-sterilised 0.2% glucose and 20 
buffered to a pH of 7.0 with 0.165 molL-1 3-(N-Morpholino) propanesulfonic acid (MOPS) 21 
(Sigma) (CLSI M38-A method from CLSI 2008). All procedures were performed under aseptic 22 
conditions in sterile 96-wellmicrotiter plates. The fungal spore suspension was prepared 23 
using the extracted spores from the fully sporulated plates in 5 ml of sterile 0.01 % Tween 24 
80 (v/v) supplemented with glass beads. Spores were counted using a haemocytometer and 25 
adjusted to the desired concentration (2x106 spore.ml-1) to inoculate 5 ml the half strength 26 
RPMI-1640 medium. The prepared broth spore suspension (90 μl) was added to the wells 27 
(Troskie et al. 2012). Each well contained a total of 1.8x104 spores. Dried pheromone 28 
mixture was dissolved in 1% Dimethyl sulfoxide (DMSO) to a concentration of 13 µgml-1. 29 
Serial dilutions (6.5, 3.25, 1.62, 0.8, 0.4, 0.2, 0.1, 0.05 µgml-1) were made using 1% DMSO 30 
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and then 10 μl of these diluted pheromone mixtures were added to the wells containing  1 
90 μl broth suspension. Control culture (positive) received 10 μl of 1% DMSO instead of 2 
pheromone. Control negative was a combination of half strength RPMI-1640 (90 μl) and 1% 3 
DMSO (10 μl) to confirm the sterile RPMI-1640 and DMSO used in the wells. All wells 4 
contained a final volume of 100 μl. Subsequent to the pheromone addition, the microtiter 5 
plate was covered tightly with tinfoil, sealed with parafilm and incubated at 27 °C for 48 h. 6 
The absorbance of the cultures in the wells was spectrophotometrically determined at  7 
530 nm after 48 h incubation. 8 
Aflatoxin gene expression study in A. flavus using reverse transcriptase polymerase chain 9 
reaction (RT-PCR)  10 
A. flavus which was grown on PDA medium with different treatments kept at -20 ᵒC for this 11 
experiment. The cultures were harvested using the scalpel to collect 100 mg fungal biomass. 12 
Total RNA was extracted using RNeasy Mini Plant Kit (Qiagen) according to the 13 
manufacturer’s instructions. All RNA samples were treated by using QIAGEN RNase-Free 14 
DNase Set (Qiagen, UK) to digest contaminating genomic DNA in RNA solutions prior to RNA 15 
clean up and concentration (using the RNeasy MinElute Cleanup kit (Qiagen, UK)). 16 
Complementary DNA (cDNA) synthesis from A. flavus mRNA was carried out using Revert 17 
Aid First Strand cDNA Synthesis Kit (Thermo Scientific, UK) according to the manufacturer’s 18 
instructions. 19 
The synthesised cDNA from all RNA samples were amplified using the conventional PCR. The 20 
amplification reaction was carried out by utilising PCR master mix (Promega, Southampton, 21 
UK). The PCR reaction was prepared according to the manufacture instructions. The PCR 22 
conditions were optimised for applying combined primes; aflp primers for aflatoxin gene (F-23 
aflP/R-aflP) and ITS primers for housekeeping genes (ITS1/ITS4) (details are given in Table 24 
S5). The amplification program was started with initial denaturation at 94 °C for 2 min and 25 
followed with 35 cycles of denaturation at 94 °C, annealing at 55 °C and extension at 72 °C 26 
all for 1 min. Final extension was for 5 min at 72 °C. On completion of the PCR reaction, 8 µl 27 
of each PCR product was subjected to electrophoresis on a 2% agarose gel containing 28 
ethidium bromide. Following electrophoresis, bands corresponding to transcripts of the 29 
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study gene, aflP, and the reference gene, ITS, were noted. The gel was photographed using 1 
UVITEC Imaging System (Cambridge, UK).  2 
Results 3 
B. licheniformis NCIMB 8874 and its QSM inhibit the growth of A. flavus 4 
To investigate the antifungal potential of B. licheniformis NCIMB 8874, we initially examined 5 
if this strain had any effects on the growth of A. flavus NRL 3375 and the non-aflatoxigenic 6 
strain ESP 15. Thus, medium (104 cfu/ml) or high (109 cfu/ml) concentrations of live  7 
B. licheniformis cells were mixed with melted potato dextrose agar (PDA), PDA plates were 8 
spot inoculated with 108 spore.ml-1 A. flavus and colony growth was documented at daily 9 
intervals during a 7-day incubation at 27 oC (Fig. 1). 10 
These treatments appeared to dose-dependently reduce A. flavus growth by ≥ 66% +/- 2.5 11 
in both A. flavus species (average inhibition percentage, Fig. 2 and Table S2). To determine 12 
whether the observed effect was on account of the ComX pheromone, the comQX locus was 13 
cloned into E. coli BL21 under IPTG control and supernatant filtrates from the resulting  14 
E. coli transformants were used to prepare A. flavus PDA plates. As this resulted only in 15 
minor A. flavus growth inhibition (7.8% +/- 2.5 in A. flavus NRRL 3357; 10.5% +/- 6.0 in A. 16 
flavus ESP 15) which was nonetheless higher than the no IPTG and E. coli BL21 controls, 17 
recombinant ComX was purified, concentrated and used instead, at either high (30 mgml-1) 18 
or low (5 mgml-1) concentrations. These treatments reduced A. flavus growth by 56% +/-8 19 
(NRRL 3357) or 53% +/- 3.5 (ESP 15) at high ComX concentration, and 8% +/-3.5 (NRRL 3357) 20 
or 2.5% +/- 1.3 (ESP 15) at low ComX concentration, respectively. As spent, mid-exponential 21 
growth phase B. licheniformis media had comparable impact on A. flavus growth inhibition 22 
to the low recombinant ComX preparation, we reasoned ComX levels remained reduced 23 
during this stage of B. licheniformis growth (Fig. 2 and supplementary information, Tables 24 
S1-S3 and Fig. S4). 25 
To examine whether the effect of B. licheniformis on A. flavus growth was on account of 26 
ComX in B. licheniformis supernatant, medium (104 cfu/ml) or high (109 cfu/ml) 27 
concentrations of B. licheniformis were washed 3x with sterile water and resuspended in 28 
sterile water before PDA plate preparation. Interestingly, only the high concentration of 29 
washed and resuspended B. licheniformis cells impacted upon A. flavus growth (48% +/- 5.8 30 
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in NRRL 3357 or 41% +/- 1.3 in ESP 15), with the low concentration exhibiting an effect 1 
comparable to mid-exponential phase B. licheniformis supernatant or ComX-recombinant  2 
E. coli supernatant. Moreover, the effect of washed B. licheniformis cells was 24%-30% 3 
lower than that of unwashed cells, suggesting that both cellular and exocytosed ComX 4 
contributed to A. flavus growth inhibition. 5 
To determine whether these observations translated into a reduced mass of A. flavus, these 6 
experiments were repeated with suspension A. flavus cultures for both A. flavus NRRL 3357 7 
and ESP 15, and dry mass was measured after suspension filtration and desiccation (Fig. 3). 8 
Thus, dry mass measurements compared to paired control experiments (no treatment) 9 
confirmed that the plated A. flavus growth inhibition observations were statistically 10 
significant (p < 0.05, n=3). Additionally, these experiments indicated that recombinant ComX 11 
from E. coli supernatants was also able to inhibit fungal growth, but that this was 12 
statistically significant only in liquid culture. In contrast, the inhibition levels observed in 13 
liquid culture were not as relatively extensive as the ones observed on solid PDA media. 14 
Interestingly, the findings with aflatoxigenic A. flavus NRLL 3357 were reproduced with the 15 
non-alfatoxigenic A. flavus ESP 15 strain. Taken together, these results raised the hypothesis 16 
that B. licheniformis ComX may possess broad antifungal properties against A. flavus. 17 
To test this hypothesis, the standard, microtitre-based antifungal susceptibility assay CLSI 18 
M38-A (CLSI 2008) was carried out to identify a threshold antifungal concentration for the 19 
semi-purified ComX pheromone produced in E. coli (Fig. 4). Thus, double dilution series 20 
starting at 13 µgml-1 resulted in 77% growth inhibition (p ≤ 0.05, n=4) at the highest purified 21 
ComX concentration tested. As this is classified as slight growth, score 4, according to the 22 
standard CLSI protocol, these data document a high antifungal effect of the pheromone on 23 
fungal growth. 24 
B. licheniformis and its ComX QSM inhibit aflatoxin gene expression in A. flavus 25 
To explore the impact of these supplementations on aflatoxin production, A. flavus aflP 26 
gene expression was explored by exon-spanning, end point reverse transcription 27 
polymerase chain reaction (RT-PCR), against the A. flavus ITS housekeeping gene, as efforts 28 
to identify optimally performing, wide range, log-linear real time intercalator primer sets for 29 
both genes proved problematic. Thus application of vehicle (DMSO), no treatment control 30 
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(water) or supernatants of a washed 104 cfu/ml, but not 109 cfu/ml Bacillus suspension on 1 
aflatoxigenic A. flavus NRRL 3357 yielded 121 bp cDNA amplicons indicative of aflP mRNA 2 
production against robust gDNA gene detection (Fig. 5). Furthermore, the data indicated 3 
very weak levels of aflP expression by this end point, 40 cycle assay, explaining limitations in 4 
quantification efforts, and highlighting the inhibitory effect of recombinant ComX in aflP 5 
expression.   6 
Discussion 7 
Previous studies reported that Bacillus species (B. subtilis and B. licheniformis), 8 
Pseudomonas, Ralstonia and Burkholderia strains could completely inhibit A. flavus growth 9 
and aflatoxin production (Nesci et al. 2005; Palumbo et al. 2006). Moreover, the bio-control 10 
agents B. subtilis, P. fluorescens and Trichoderma viride showed >65% inhibition in  11 
A. flavus growth (Reddy et al. 2010). Our study investigates the antagonistic effect of the  12 
B. licheniformis strain NCIMB 8874 on aflatoxigenic and non-aflatoxigenic strains of  13 
A. flavus, and is the first to examine the effects of B. licheniformis QSM ComX on fungal 14 
growth. Thus, by using different concentrations of B. licheniformis and its ComX pheromone 15 
recombinantly expressed in E. coli, we demonstrate statistically significant growth inhibition 16 
of A. flavus. These experiments indicate that, over the space of one week, ComX may 17 
prevent both the surface spread and reproduction capacity of the fungus, as plate-based 18 
growth was inhibited by ~70% and fungus dry mass increase in liquid culture was also 19 
significantly curtailed. Furthermore, the relatively weak levels of aflP expression, the  20 
A. flavus gene encoding for aflatoxin, were reduced below assay detection limit after 21 
exposure to wild type or recombinant ComX. Exploring such components of organisms 22 
antagonistic to A. flavus with inhibitory potential to pathogen growth and toxigenicity are 23 
expected to provide a better insight into ways to overcome or limit infection in both plants 24 
and mammals.  25 
In line with this hypothesis, it has been recently suggested that a B. licheniformis strain 26 
associated with the marine organism Spongia officinalis has inhibitory and anti-biofilm 27 
activity on E. coli and P. fluorescens by secreting a complex exo-polysaccharide compound 28 
(Sayem et al. 2011). Elsewhere, A. fumigatus biofilm formation was inhibited by co-culturing 29 
of P. aeruginosa; a secreted heat-stable factor (decanol and decanoic acid, analogous to 30 
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Pseudomonas QSMs) was shown to exhibit biofilm inhibition. Based on this finding, it was 1 
hypothesised that QSMs affected fungal growth (Ramage et al. 2011) and could offer a 2 
starting point for antifungal drug discovery research efforts. Overall, it has been suggested 3 
that small diffusible and heat-stable molecules might be responsible for the competitive 4 
inhibition of filamentous fungal growth in environments with potential for polymicrobial 5 
colonisation such as the lung, and this could be exploited as a potential therapeutic strategy 6 
(Mowat et al. 2008; Seidler et al. 2008). Indeed, there are other instances in the literature 7 
where QSMs have been reported to exhibit antimicrobial activity. Thus, a gram-negative 8 
QSM (AHL) and its derived tetramic acid was shown to be bactericidal against Gram-positive 9 
bacteria (Kaufmann et al. 2005). Tetramic acids have been known to display mycotoxic, 10 
antibacterial and antiviral activities (Wang et al. 2003; Evans et al. 2006; Yu et al. 2007). 11 
The current study examined the antagonistic effect of B. licheniformis NCIMB-8874 on 12 
Aspergillus growth under co-culture conditions. The results showed that B. licheniformis 13 
cells cause a significant reduction in A. flavus growth, whether in solid or liquid phase (Fig. 2 14 
and 3). Moreover, at high concentrations of B. licheniformis (109 cfu/ml inoculum), the 15 
effect did not appear to rely entirely on ComX release, as washing of the bacilli did not 16 
eliminate their antifungal potential. Accordingly, cell-free supernatant of B. licheniformis 17 
from the exponential growth phase showed a negligible decrease in the fungal growth, 18 
reinforcing the tenet that bacterial cells in the fungal culture are the effective factor on 19 
fungal growth reduction rather than the cell-free supernatant. In this scenario, the bacterial 20 
cells would compete against fungus, and/or secrete/employ their antimicrobial molecules 21 
under the co-culture condition. These results are comparable to previous studies on 22 
antagonising microorganisms (Nesci et al. 2005; Reddy et al. 2010), and indicate  23 
B. licheniformis may directly antagonise Aspergillus.  24 
Alternatively, key nutrient depletion in co-culture conditions and the differential growth 25 
rates of A. flavus and B. licheniformis, especially at the inoculation ratios where 109 cfu of  26 
B. licheniformis were used, could explain these observations. However, the PDA medium is 27 
rich enough to make it unlikely that the nutrients would be sequestered by the bacteria, 28 
inhibiting A. flavus spread to the extent we observed. On the other hand, B. licheniformis 29 
monoculture may enrich extracellular media with proteins and metabolites distinct to those 30 
produced under co-culture with A. flavus. In agreement with this interpretation, Losada and 31 
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co-workers (Losada et al. 2009) performed co-cultivation competition assays among 1 
different species of Aspergillus, to observe that Aspergillus extracts had greater antifungal 2 
activity when they were grown in the presence of a competitor. More importantly, gas 3 
chromatography experiments supported this hypothesis, indicating that Aspergillus extract 4 
composition was altered due to the use of competitor organisms. It is thus likely that, 5 
although not explicitly tested, these findings extend to the co-culture conditions we have 6 
explored herein.  7 
In our hands, both washed and unwashed Bacillus cells exerted inhibitory effects on fungal 8 
growth, but to different degrees. Thus, assuming ComX as the causal factor to A. flavus 9 
growth inhibition, washing of B. licheniformis cells appeared to reduce antifungal potential, 10 
probably by eliminating cell-free ComX from the media. However, as the co-culture assay 11 
conditions permitted the washed B. licheniformis cells to grow and produce fresh ComX, our 12 
data indicated the bacterial cells were able to reinstate ComX to levels inhibitory to A. flavus 13 
growth. In line with this interpretation, low concentrations of recombinant ComX arising 14 
from recombinant E. coli supernatants or recombinant E. coli cell extracts (5 mg/ml) failed 15 
to appreciably inhibit A. flavus, as did the supernatants of non-induced recombinant E. coli 16 
and non-recombinant E. coli (Table S2 and S3). Thus, only 30 mg/ml of recombinant ComX  17 
E. coli extract impacted A. flavus growth and spread. 18 
Crucially, the findings with solid A. flavus culture were generally well-reproduced with liquid 19 
culture assessing the impact of B. licheniformis and recombinant ComX in terms of fungal 20 
dry weight (Fig. 3).  However, in this assay, the supernatants from the recombinant E. coli 21 
cells induced with IPTG to express ComX resulted in a significant reduction in fungal dry 22 
weight. This may be attributable to poorly detectable minor growth reduction in fungal 23 
colony surface area, which might not be as easily measurable as loss of dry mass over a 7- 24 
day suspension incubation.  Thus, the cumulative growth reduction in the dry weight assay 25 
over the 7 days incubation period might enable detection of significant change in the whole 26 
fungal mass. Alternatively, differential diffusion rates and concentration levels of ComX 27 
through solid PDA vs. shaken liquid culture could account for differences in inhibition 28 
efficiency across the colony volume.   29 
13 
 
The fungal inhibition observation showed that dry mass reductions are more notable in solid 1 
plated-base culture as opposed to suspension culture. To discuss, specifically, local ComX 2 
gradient effects in solid culture would have a more pronounced inhibitory effect to proximal 3 
fungal cells, which would result in reduced surface area growth and total mass. Accordingly, 4 
the volume occupied by ComX secretions is vastly smaller to that of liquid culture. By stark 5 
contrast, rapid diffusion in liquid culture would require much higher absolute quantity of 6 
ComX to be produced to achieve concentrations comparable to that in solid culture. 7 
Moreover, the substantial differences in microbial physiology between the two growth 8 
phases adequately explain our observations. Accordingly, this multifaceted molecular 9 
evidence regarding the inhibited processes would be relevant to a drug development 10 
program such as using appropriate and condition-relevant models in the future. 11 
Having said that DNA quantification could be an alternative line of evidence for liquid 12 
culture which would add another quality control to experiments relevant to the infection 13 
control being attempted in a commercial, or nosocomial setting. Indeed, in respiratory care, 14 
the concentrations of ComX in airway surface liquid after nebuliser administration would be 15 
closer to those achieved in solid culture than bulk volume liquid culture, simply on account 16 
of the physiology of the airways. 17 
With the antifungal potential of ComX suggested thus, and the impact of microorganismal 18 
growth rates remaining unresolved, we proceeded to reassess the effect of ComX using low 19 
nutritional value media (RPMI-1640) in a microtitere plate-based, standard antifungal 20 
susceptibility assay. Identifying 13 µgml-1 as the minimum inhibitory concentration (MIC), 21 
CLSI classification indicated “slight growth” for Aspergillus at this ComX pheromone 22 
concentration. Crucially, this concentration is comparable to many established antifungal 23 
agents (Lewis 2011), even before structure-activity relationship exploration and derivative 24 
pharmacology is pursued. This raw potency highlights the pharmacoeconomic potential of 25 
pursuing inter-kingdom QS pheromone research. 26 
On the basis of the food safety and medical risks presented by A. flavus and related strains 27 
through production of aflatoxins, we therefore sought to investigate whether ComX might 28 
extend its utility to preventing aflatoxin gene expression. We reasoned this biomarker assay 29 
to be a simpler, more sensitive, specific and safe approach than aflatoxin purification and 30 
14 
 
quantification from ComX-treated A. flavus for the early research. However, direct and 1 
dose-dependent measurement of aflatoxin production inhibition pharmacology has been 2 
induced as part of the future development of the ComX compound. 3 
Leema and colleagues (2011) had successfully used RT-qPCR to investigate the expression of 4 
aflR, aflJ, aflC and aflD as surrogates of aflatoxin production in A. flavus isolated from 5 
keratitis patients. Two genes, aflD and aflJ, encode the enzymes to synthesize 6 
sterigmatocystin (aflatoxin precursor), although aflC encodes a polyketide synthase and aflR 7 
is a biosynthesis regulator. All these genes are important in the earlier stages of biosynthesis 8 
pathway. As, however, aflP encodes O-methyltransferase A, which converts the A. flavus 9 
aflatoxin B1 precursor sterigmatocystin to O-methylsterigmatocystin, as well as 10 
demethylsterigmatocystin to dihydro-O-methylsterigmatocystin (Abdel-Hadi et al. 2011), 11 
and has been causally linked to aflatoxin production (Rahimi et al. 2016), we sought to 12 
establish the expression of this nodal enzyme in the aflatoxin biosynthesis pathway instead. 13 
Moreover, other members of aflatoxin gene cluster involved in different steps of 14 
biosynthetic pathway (e.g. aflR, aflJ, aflC and aflD) would be worth to be investigated in 15 
order to immensely transcriptomic study on aflatoxin in the future research. 16 
Furthermore, we explored if B. licheniformis in general and ComX specifically had a direct 17 
effect on the expression levels of this gene. In our hands, testing three separate primer sets 18 
for intercalator dye real time RT-PCR failed to identify suitably robust assays, probably due 19 
to the very low levels of aflP expression as suggested by an endpoint assay (Fig. 5). 20 
However, the effect of bacillus supernatants and ComX universally reduced aflP mRNA 21 
levels below the detection limit of this assay. This finding would suggest that QS effect of 22 
ComX might extend to aflatoxin production inhibition in addition to antifungal growth 23 
properties, ultimately arresting aflatoxin biosynthesis. However, further studies are needed 24 
on the expression dynamics of aflP. For example, unexpected amplicons in the end point 25 
assay may at first glance suggest splicing changes in aflP expression, their <75 bp size upon 26 
weak gDNA copy amplification is indicative of PCR artefacts. Similarly, problems with 27 
quantitative assay performance did not encourage us to explore exhaustively endogenous 28 
reference genes beyond ITS, as recently elegantly described in Talaromyces versatilis (Llanos 29 
et al. 2015). The report from Llanos and colleague (2015) indicated the reliable reference 30 
genes including; ubcB, sac7, fis1 and sarA genes, as well as TFC1 and UBC6 that were 31 
15 
 
previously validated for their use in S. cerevisiae. Unlike these reported reference genes, in 1 
the current study, the weak expression of ITS (as a reference gene) was obtained from one 2 
test, low concentrated washed Bacillus cells (Figure 5). The result displays the possible 3 
impact of this treatment on the expression level of the conserved gene such as ITS. Also, we 4 
reasoned that mean geometric average levels of expression of multiple reference genes is 5 
relevant only in real time expression normalisation against unexpected treatment effects to 6 
so-called housekeeping genes, and for improved target loading normalisation relative to 7 
RNA stability. Confirmatory studies on the anti-aflatoxigenicity of ComX or its derivatives will 8 
thus require in depth characterisation of their effects on aflP both kinetically, and in the 9 
context of cell cycle homeostasis (mechanism of action studies). 10 
The effects of ComX on aflatoxin production notwithstanding, it is now well established that 11 
QS plays a major role in the inter-kingdom cross-talk. AHL as a bacterial QSM is an example 12 
recognised by eukaryotic cells (e.g. animal cells, plants, seaweed and fungi; Dudler and Eberl 13 
2006). Besides, farnesol as a fungal QSM from C. albicans has been reported to decrease the 14 
production of Pseudomonas QSM. It is further suggested that farnesol and the related 15 
compounds may participate in interspecies interactions (Cugini et al. 2007). Fungi coexist 16 
with bacteria in the environment, and bio-chemical exchange between them is a method of 17 
communication. The QS-like behaviour in filamentous fungi was reported in  18 
A. terreus (Schimmel et al. 1998), A. flavus (Brown et al. 2008 and 2009) and A. nidulans 19 
(Williams et al. 2012). It thus seems that QS is an established mechanism used by fungi to 20 
modulate mutualresponses to each other and their environment (Sorrentino 2010). Also, 21 
instances of small molecule exchange between bacteria and eukaryotes have been reported 22 
(Mullard 2009) and examples of QS processes involved in the interspecies communications 23 
have emerged (Lu et al. 2014). Considering these recent findings, it can be suggested that 24 
the communication between A. flavus as a filamentous fungus, which has its own QS 25 
network, and its B. licheniformis antagonist might occur through their QS systems. While 26 
this needs to be further investigated, this study reveals the significant influence of  27 
B. licheniformis NCIMB-8874QSM on growth of Aspergillus, expanding evidence suggesting 28 
inter-kingdom cross-talk through the QS systems of these organisms. 29 
This study confirmed the antagonistic activity of B. licheniformisNCIMB-8874 against  30 
A. flavus, and the role of the natural antifungal peptide, ComX pheromone, crucial for 31 
16 
 
bacterial competence. The results support further research into this B. licheniformis strain 1 
either directly or on its ComX product as a natural antifungal agent to promote a sustainable 2 
bio-control strategy for agricultural crops and airways disease, by exploiting inter-kingdom 3 
cross-talk either chemically, biochemically, or even through genetic engineering. 4 
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Figures legends 1 
Fig. 1 Diagram of the fungal growth experiment 2 
Fig. 2 The B. licheniformis ComX pheromone inhibits A. flavus growth.  The impact of  3 
B. licheniformis NCIMB 8874 or its ComX pheromone recombinantly expressed in E. coli 4 
under IPTG control was evaluated on A. flavus NRRL 3357 (Panel A) and A. flavus ESP 15 5 
(Panel B) cultures at different concentrations and preparation formats. Highly concentrated 6 
B. licheniformis cells appear to contain and have released ComX to concentrations inhibiting 7 
A. flavus growth comparable to 30 mg/ml recombinant, ComX-expressing E. coli cell 8 
extracts. Data representative of two independent experiments in triplicates are presented. 9 
Fig. 3 Fungal dry weight data of A. flavus NRLL 3357 (Panel A) and A. flavus ESP 15 (Panel B) 10 
(Calculated weight, g, of fungal dry mass which was grown in 10 ml PDB in the presence of 11 
different treatments, in triplicates). (*) indicates a significant difference between the test 12 
and the control (P≤0.05). 13 
Fig. 4 Antifungal potential of recombinant ComX by CLSI M38-A assay. A. flavus NRLL 14 
3357suspension culture was incubated with decreasing concentrations of recombinant 15 
ComX in RPMI for 48h and A. flavus growth was measured by absorbance at 530 nm. Fungal 16 
growth is expressed as the average growth of four replicates +/- standard deviation, relative 17 
to the average growth observed among no ComX controls (0 µgml-1). Data representative of 18 
two independent experiments are presented.   19 
Fig. 5 Endpoint RT-PCR aflP expression in A. flavus in response to B. licheniformis or 20 
recombinant ComX treatment. Exon-spanning primers to the A. flavus aflP gene yield 181 bp 21 
genomic, and 121 bp mRNA-derived amplicons confirmatory of aflatoxigenic A. flavus strain 22 
identity, and weak aflP expression in the absence of the antagonistic B. licheniformis ComX 23 
pheromone. The white arrow indicates the weak aflp mRNA band position in A. flavus NRL 24 
3357. A ~600 bp amplicon corresponds to ITS amplification is as a reference gene. M: 25 bp 25 
marker. 26 
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